DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Barry Myers is a featured speaker at CED’s MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
